Print Page | Sign In | Join
News & Press
Filter news by category:

Read about recent events, essential information and the latest community news.

Displaying page 20 of 27
 |<   <<   <  15  |  16  |  17  |  18  |  19  |  20  |  21  |  22  |  23  |  24  |  25  >   >>   >| 

Scientific Advancements
Tuesday, February 11, 2020   (0 Comments - view/add)
Last Patient Last Visit in Cyclo Therapeutics’ Phase I Trial in Niemann-Pick Type C »
Last Patient Last Visit in Cyclo Therapeutics’ Phase I Trial in Niemann-Pick Type C Data cleaning underway, top lin...
Tuesday, February 11, 2020   (0 Comments - view/add)
AIM ImmunoTech Files Three Provisional Patent Applications Surrounding Ampligen® for Use Against the »
AIM ImmunoTech Files Three Provisional Patent Applications Surrounding Ampligen® for Use Against the SARS-like Wuhan 2019...
Monday, February 10, 2020   (0 Comments - view/add)
RIST Neurovascular, Inc. Announces FDA Clearance of the First Catheter Specifically Designed to Acce »
RIST Neurovascular, Inc. Announces FDA Clearance of the First Catheter Specifically Designed to Access the Neurovasculatur...
Monday, February 3, 2020   (0 Comments - view/add)
TherapeuticsMD Announces Submission of New Drug Application Prior Approval Efficacy Supplement to th »
TherapeuticsMD Announces Submission of New Drug Application Prior Approval Efficacy Supplement to the U.S. Food and Drug A...
Thursday, January 23, 2020   (0 Comments - view/add)
AGTC Reports Encouraging Interim Six-Month Data from the Dose Escalation Cohorts of its Ongoing Phas »
AGTC Reports Encouraging Interim Six-Month Data from the Dose Escalation Cohorts of its Ongoing Phase 1/2 Clinical Trials...
Wednesday, January 22, 2020   (0 Comments - view/add)
INHIBITOR Therapeutics Receives prostate cancer IND Clearance from FDA »
INHIBITOR Therapeutics Receives prostate cancer IND Clearance from FDA SUBA™-Itraconazole to be Tested in Combination w...
Thursday, January 9, 2020   (0 Comments - view/add)
AGTC Reports Positive Six-Month Data from its Ongoing Phase 1/2 Clinical Trial in X-Linked Retinitis »
AGTC Reports Positive Six-Month Data from its Ongoing Phase 1/2 Clinical Trial in X-Linked Retinitis Pigmentosa  ...
Friday, December 20, 2019   (0 Comments - view/add)
Longeveron LLC Announces Completion of Enrollment in Phase 1 Clinical Trial of Longeveron Allogeneic »
Longeveron LLC Announces Completion of Enrollment in Phase 1 Clinical Trial of Longeveron Allogeneic Mesenchymal Stem Cell...
Monday, December 16, 2019   (0 Comments - view/add)
Boca Raton Regional Hospital implements long-term monitoring system to help prevent future stroke »
Boca Raton Regional Hospital implements long-term monitoring system to help prevent future stroke BOCA RATON, FL – D...
Monday, December 9, 2019   (0 Comments - view/add)
etectRx Announces U.S. FDA Clearance of Novel Ingestible Event Marker »
etectRx Announces U.S. FDA Clearance of Novel Ingestible Event Marker   ID-Cap System Uses Advanced Wireless...
Wednesday, December 4, 2019   (0 Comments - view/add)
AdventHealth Nicholson Center Unveils 3D Printing Prototype Lab »
AdventHealth Nicholson Center Unveils 3D Printing Prototype Lab Nicholson Center clients can now bring their ideas to...
Monday, November 25, 2019   (0 Comments - view/add)
INHIBITOR Therapeutics Submits Investigational New Drug Application for Treatment of Patients with L »
INHIBITOR Therapeutics Submits Investigational New Drug Application for Treatment of Patients with Late-Stage Prostate Can...
Friday, November 15, 2019   (0 Comments - view/add)
Oragenics, Inc. Publishes Peer-Reviewed Study in Journal of Peptide Science Demonstrating First Comp »
Oragenics, Inc. Publishes Peer-Reviewed Study in Journal of Peptide Science Demonstrating First Complete Chemical Synthe...
Tuesday, November 5, 2019   (0 Comments - view/add)
AGTC Announces Stargardt Disease as its Second Preclinical Ophthalmology Program and Reports Compell »
AGTC Announces Stargardt Disease as its Second Preclinical Ophthalmology Program and Reports Compelling Preclinical Data S...
Wednesday, October 30, 2019   (0 Comments - view/add)
Ziptek Update: 1-Year Results of First 25 Rotator Cuff Patients Treated with ZipE® »
Ziptek Update: 1-Year Results of First 25 Rotator Cuff Patients Treated with ZipE® October 30, 2019, 1:15 pm...
Monday, October 28, 2019   (0 Comments - view/add)
Cyclo Therapeutics Prepares for Alzheimer’s Development Program After Success with First Patient »
Cyclo Therapeutics Prepares for Alzheimer’s Development Program After Success with First Patient   ORLANDO, FL...
Tuesday, October 22, 2019   (0 Comments - view/add)
Cyclo Therapeutics Announces Completion of Enrollment in its Phase I Trial to Evaluate Trappsol® Cyc »
Cyclo Therapeutics Announces Completion of Enrollment in its Phase I Trial to Evaluate Trappsol® Cyclo™ for the Treatment...
Tuesday, September 17, 2019   (0 Comments - view/add)
20Lighter Announces Peer-Reviewed Publication of Weight Loss Program Clinical Data »
20Lighter Announces Peer-Reviewed Publication of Weight Loss Program Clinical Data By: 20Lighter, LLC  ...
Monday, September 9, 2019   (0 Comments - view/add)
Nano Discovery Inc. Launches a New Blood Test for Cattle Immune Health Testing »
Nano Discovery Inc. Launches a New Blood Test for Cattle Immune Health Testing   ORLANDO, Fla.--( BUSINESS W...
Friday, September 6, 2019   (0 Comments - view/add)
Ridgeback Biotherapeutics LP announces receipt of Breakthrough Therapy designation from FDA for mAb1 »
Ridgeback Biotherapeutics LP announces receipt of Breakthrough Therapy designation from FDA for mAb114 MIAMI , Sept....
Thursday, September 5, 2019   (0 Comments - view/add)
ZyVersa Therapeutics Advances Development of Lead Inflammasome Inhibitor Candidate, IC 100 »
ZyVersa Therapeutics Advances Development of Lead Inflammasome Inhibitor Candidate, IC 100   IC 100 is a novel...
Thursday, August 29, 2019   (0 Comments - view/add)
OPKO Completes Pivotal Phase 3 Study for Somatrogon (hGH-CTP), an Investigational Long-Acting Growth »
OPKO Completes Pivotal Phase 3 Study for Somatrogon (hGH-CTP), an Investigational Long-Acting Growth Hormone Being Studied...
Friday, August 23, 2019   (0 Comments - view/add)
Mayo Clinic and United Therapeutics to increase lungs for transplantation in new building dedicated »
By Kevin Punsky   Mayo Clinic and United Therapeutics to increase lungs for transplantation in new build...
Friday, August 16, 2019   (0 Comments - view/add)
Discovery of anti-opioid pathway offers new route to designing safer pain medications »
Discovery of anti-opioid pathway offers new route to designing safer pain medications   August 16, 2019...
Monday, August 12, 2019   (0 Comments - view/add)
Ridgeback Biotherapeutics LP announces an update on mAb114, an experimental treatment for Ebola »
Ridgeback Biotherapeutics LP announces an update on mAb114, an experimental treatment for Ebola MIAMI , Aug. 12, 2019...
Thursday, August 8, 2019   (0 Comments - view/add)
Scientists discover ‘forgetting’ enzyme that lops brain cell branches »
Scientists discover ‘forgetting’ enzyme that lops brain cell branches JUPITER, Fla. — Aug. 8, 2019 — An enzyme cal...
Tuesday, July 30, 2019   (0 Comments - view/add)
New Startup Biotech Company Plans to Test Promising Herpes Vaccine for Both HSV-1 and HSV-2 »
New Startup Biotech Company Plans to Test Promising Herpes Vaccine for Both HSV-1 and HSV-2 CLEARWATER, Fla. , July 3...
Tuesday, July 23, 2019   (0 Comments - view/add)
AGTC Completes Enrollment of Third Group in the Dose Escalation Portion of the Achromatopsia CNGA3 P »
AGTC Completes Enrollment of Third Group in the Dose Escalation Portion of the Achromatopsia CNGA3 Phase 1/2 Clinical Stud...
Monday, July 22, 2019   (0 Comments - view/add)
Alz1 Launches the First At-Home Solution to Detect, Help Reduce Risk Factor Associated with Alzheime »
Alz1 Launches the First At-Home Solution to Detect, Help Reduce Risk Factor Associated with Alzheimer’s Disease...
Wednesday, June 26, 2019   (0 Comments - view/add)
Precigen Announces First Patient Dosed in Phase 1/1b Study of PRGN-3006 UltraCAR-T™ in Patients with »
Precigen Announces First Patient Dosed in Phase 1/1b Study of PRGN-3006 UltraCAR-T™ in Patients with Relapsed or Refractor...
Tuesday, June 25, 2019   (0 Comments - view/add)
ILiAD Biotechnologies Announces First Patient Enrolled in BPZE1 Pertussis Vaccine Multicenter Phase »
ILiAD Biotechnologies Announces First Patient Enrolled in BPZE1 Pertussis Vaccine Multicenter Phase 2b Clinical Trial...
Wednesday, June 19, 2019   (0 Comments - view/add)
Human-on-a-chip Model Enables Simultaneous Testing of Cancer Drug Efficacy and Off-Target Toxicity t »
Human-on-a-chip Model Enables Simultaneous Testing of Cancer Drug Efficacy and Off-Target Toxicity to Enable Determination...
Thursday, June 13, 2019   (0 Comments - view/add)
GT Biopharma GTB-1550 »
GT Biopharma GTB-1550 Multi-Targeted Bispecific Drug Conjugate Strategically positioned in new class of ADC Drugs...
Thursday, June 6, 2019   (0 Comments - view/add)
RTI Surgical® Reaches 5,000 Implant Milestone for Fortilink® Interbody Fusion Systems with TETRAfuse »
RTI Surgical® Reaches 5,000 Implant Milestone for Fortilink® Interbody Fusion Systems with TETRAfuse® 3D Technology De...
Monday, May 20, 2019   (0 Comments - view/add)
Oragenics, Inc. Provides Development Update of AG013 for Oral Mucositis »
Oragenics, Inc. Provides Development Update of AG013 for Oral Mucositis   Phase 2 Clinical Trial Enrollment...

Displaying page 20 of 27
 |<   <<   <  15  |  16  |  17  |  18  |  19  |  20  |  21  |  22  |  23  |  24  |  25  >   >>   >| 

About BioFlorida

BioFlorida is the voice of Florida's life sciences industry, representing 8,600 establishments and research organizations in the BioPharma, MedTech, Digital Health and Health Systems that collectively employ nearly 107,000 Floridians. Source: TEConomy/BIO (released 2022)